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Mutations in three different genes have been implicated in 
familial hemiplegic migraine (FHM), two of them code for 
neuronal voltage-gated cation channels, CACNA1A and SCN1A, 
while the third encodes ATP1A2, the α2-isoform of the Na+/
K+-ATPase’s catalytic subunit, thus classifying FHM as an ion 
channel/ion transporter disorder. The Na+/K+-ATPase maintains 
the physiological gradients for Na+ and K+ ions and is therefore 
critical for the activity of ion channels and transporters involved 
in neurotransmitter uptake or Ca2+ signaling. Diverse functional 
abnormalities have been identified for disease-linked ATP1A2 
mutations, which reach far beyond simple loss-of-function. We 
have shown recently that ATP1A2 mutations frequently lead to 
changes in the enzyme’s voltage-dependent properties, kinetics 
or apparent cation affinities. Here, we present functional data 
on a so far uncharacterized set of ATP1A2 mutations (G301R, 
R908Q and P979L) upon expression in Xenopus oocytes and 
HEK293FT cells, and provide evidence for a novel pathophysi-
ological mechanism. Whereas the G301R mutant was inactive, 
no functional changes were observed for mutants R908Q and 
P979L in the oocyte expression system. However, the R908Q 
mutant was less effectively expressed in the plasma membrane of 
oocytes, making it the first missense mutation to result in defec-
tive plasma membrane targeting. Notably, the P979L mutant 
exhibited the same cellular expression profile as the wild-type 
protein, both in Xenopus oocytes and in transfected HEK293FT 
cells grown at 28°C, but much less P979L protein was found 
upon cell growth at 37°C, showing for the first time that temper-
ature-sensitive effects on protein stability can underlie ATP1A2 
loss-of-function.
Introduction
Familial hemiplegic migraine (FHM) is a rare and severe 
autosomal-dominant form of migraine with aura, which is charac-
terized by some degree of reversible motor weakness during the aura 
phase. FHM type 2 (FHM2) is caused by mutations in ATP1A2, 
the gene coding for the human Na+/K+-ATPase α2-subunit.1 
Mutations in two other genes have also been implicated in the 
disease, namely in CACNA1A (FHM1)2 and in SCN1A (FHM3),3 
which code for neuronal voltage-gated Ca2+ or Na+ channels, 
respectively, suggesting that perturbations in neuronal excitability 
underlie the neurological phenotype. Besides the involvement in 
FHM, ATP1A2 mutations have been described in sporadic forms 
of hemiplegic migraine (SHM) and also in more general types 
of migraine with or without aura (MA/MO) or even in basilar 
migraine (BM). Moreover, there is significant clinical overlap to 
other neuropathologies involving mental retardation, seizures or 
forms of epilepsy like benign familial infantile convulsions (BFIC) 
(refer to the paper by Morth and colleagues4 for a complete list). It 
is assumed in current disease models that most of the aura symp-
toms are directly linked to the phenomenon of cortical spreading 
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depression (CSD), which—starting from a certain focus on the 
neocortex—is characterized by a spreading front of neuronal exci-
tation (depolarization) that is followed by long lasting depression 
(hyperpolarization).5 Therefore, it is likely that FHM arises from 
transient neuronal hyperexcitability, very similar to epilepsy. The 
Na+/K+-ATPase is an electrogenic ion transporter, which utilizes 
ATP hydrolysis for uphill transport of 3 Na+ ions out of the cell 
and subsequent import of 2 K+ ions per reaction cycle. The enzyme 
consists of a large catalytic α-subunit and a smaller accessory 
β-subunit. Both subunit isoforms are expressed in a tissue- and 
developmental-specific manner.6 In the adult brain, the α2-subunit 
is mainly located in glial cells.7 The Na+/K+-ATPase maintains the 
physiological gradients for Na+ and K+ ions and is therefore crucial 
for proper activity of secondary active transporters, which utilize 
these gradients for transport of other solutes like e.g., Ca2+ ions or 
neurotransmitters, but also for ion channels, which are critical for 
action potential initiation or for setting the threshold of neuronal 
firing. Thus, neuronal hyperexcitability can be correlated to loss 
of Na+/K+-ATPase function in several ways: First, breakdown of 
the transmembrane K+ ion gradient would impair the repolar-
izing activity of voltage-gated K+ channels and therefore lower the 
threshold for action potential firing. Second, breakdown of the 
Na+ ion gradient would, on one hand, limit the activity of the 
neuronal Na+/Ca2+ transporter to increase Ca2+ signaling, and on 
the other hand, impair the removal of glutamate from the synaptic 
cleft by the astrocytic Na+/glutamate symporter.
Since 2003, about 50 ATP1A2 mutations have been described 
with clinical linkage to migraine, with FHM diagnosed in 36 
cases.4 To understand the primary disease-causing mechanisms, 
it is mandatory to characterize the defects caused by ATP1A2 
mutations on a molecular level. When novel ATP1A2 mutations 
are described in human genetic studies, ouabain survival assays 
are commonly carried out to probe for functional impairment.1 
However, these experiments do not allow one to draw conclu-
sions about the stage on which protein function is disrupted. The 
few studies that assayed the functional consequences of ATP1A2 
mutations by electrophysiological8 or biochemical9 techniques 
have already hinted at a broad spectrum of molecular phenotypes. 
In a preceding publication10 we have investigated the effects of 
11 FHM or SHM mutations, showing that, besides complete 
loss-of-function, subtle changes in the enzyme’s voltage-dependent 
properties or cation affinities are caused by the mutations. In addi-
tion, defects in protein expression or plasma membrane targeting 
were observed. Our previous study was focused on a certain subset 
of ATP1A2 mutations, which presumably cause disruptions of 
structurally critical H-bond patterns, and on carboxy-terminal 
mutations, including a stop codon mutation, which leads to 
an elongation of the carboxy-terminus by 28 amino acids. The 
Na+/K+-ATPase carboxy-terminus has been highlighted as a 
critical structural element for voltage-dependence and interaction 
with cations.10 In the present study, we analyze the molecular 
consequences of three additional ATP1A2 missense mutations, 
G301R11 (FHM), R908Q12 (SHM) and P979L13 (FHM), by 
measuring stationary pump currents and transient currents in 
Xenopus laevis oocytes, and monitoring protein expression in these 
and in mammalian HEK293FT cells at different temperatures.
Results and Discussion
Upon expression of WT and mutant human Na+/K+-ATPase 
α2-subunits together with the β1-subunit in Xenopus oocytes, we 
measured stationary Na+/K+ pump currents and ouabain-sensitive 
uptake of Rb+. Figure 1A shows that the stationary pump currents 
of the P979L mutant were slightly smaller compared to WT, 
whereas a reduction by about 80% was found for the R908Q 
mutant, and the currents measured on oocytes expressing the 
G301R mutant were indistinguishable from baseline fluctuations. 
Rb+ uptake was nearly identical for ATP1A2 WT and P979L, 
and largely reduced for mutants R908Q and G301R. To explore 
more subtle functional consequences, we measured the voltage and 
[K+]ext dependence of K
+-stimulated pump currents, and deter-
mined kinetics and voltage dependence of charge movement from 
ouabain-sensitive transient currents mediated by Na+/K+-ATPase 
under extracellularly high [Na+] and K+-free conditions. Although 
stationary currents of the R908Q mutant were small, a sufficient 
number of cells could be analyzed for this construct. Compared 
to the WT properties determined previously (see Fig. 3A in 
Tavraz et al.10), the stationary I-V curves of the R908Q mutant 
(Fig. 1C) were very similar. The same was true for the P979L 
mutant (Fig. 1D), and also the voltage-dependent K0.5 values 
for the [K+]ext dependence of pump currents were very similar to 
WT for R908Q (Fig. 1E) and P979L (Fig. 1F). Furthermore, the 
parameters V0.5 and zq from fits of a Boltzmann function to the 
Q-V distributions of translocated charge and turnover numbers 
were not different from the WT values for mutants R908Q and 
P979L (Table 1). For the R908Q mutant, the reciprocal time 
constants from transient currents were also identical to WT (Fig. 
1G), whereas slightly elevated rate constants were found for P979L 
(Fig. 1H). In summary, ion transport activity, as assessed by pump 
current and Rb+ uptake measurements, was almost completely lost 
for mutant G301R, largely reduced for R908Q (albeit without 
detectable functional changes on a molecular level), but unaltered 
for mutant P979L.
At this point, it was critical to determine protein expression 
levels and to monitor the relative amounts of ATP1A2 protein in 
the plasma membrane. Figure 2A shows that for the P979L mutant 
the amounts of α2-subunit protein in total membrane as well as 
plasma membrane fractions were similar to WT. However, protein 
abundance in the plasma membrane fraction was slightly smaller 
for the G301R mutant, and for R908Q severely reduced, although 
the amounts of α2-subunit protein in the total cellular membrane 
fractions were identical to WT (Fig. 2B).
Therefore, loss of activity for the G301R mutant can be 
attributed to a normally targeted but inactive enzyme, as found 
previously for mutations R764P and W887R8. Gly301 resides in 
the central portion of transmembrane helix M3 (Fig. 3) where 
it closely approaches helix M4 around Leu322 and Ile325. Thus, 
mutation to a bulky arginine is likely to distort the local structure, 
and since the adjacent residue Glu332 is part of the cation binding 
pocket,15 this putative disruption may interfere with cation coor-
dination or transport. For the R908Q mutation, deficient plasma 
membrane targeting can account for loss-of-function, although 
the mutant enzyme itself is fully functional. Reduced plasma 
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membrane expression has previously been 
observed for the S966fs frame shift muta-
tion and the deletion/insertion mutation 
del(K935-S940)ins(I),10 which represent 
severe disruptions of the primary struc-
ture and likely cause protein misfolding 
and degradation. Notably, R908Q is the 
first FHM2 missense mutation to result 
in defective plasma membrane targeting. 
Arg908 resides in the loop between trams-
membrane segments M8 and M9 and may 
be critical for structural integrity of the 
extracellular face of the Na+/K+-ATPase 
α-subunit, since the terminal amino 
group of this arginine is able to form 
an H-bond (~3.5 Å) to the backbone 
carbonyl oxygen of Leu797 in the M5-M6 
loop (Fig. 3). Reduced plasma membrane 
trafficking can also explain the previously 
published results from ouabain survival 
assays, in which a severe impairment of 
cell viability was found for cells expressing 
the R908Q mutant, although the amount 
of total cellular α2-subunit protein was not 
changed compared to WT.12
Since the P979L mutant did not 
show any functional alterations in our 
oocyte experiments at room temperature 
(20–22°C), we asked, whether a differ-
ence in the temperature dependence of the 
ion-pumping rate could lead to divergent 
activity at body temperature. This could 
happen either if the activation energy of the 
rate-limiting step for ion pumping by the 
P979L mutant protein would be different 
from that of the WT protein, or if at 
elevated temperature, another partial reac-
tion of the catalytic cycle with a different 
temperature dependence would become 
rate limiting. To explore this possibility, 
we measured the temperature dependence 
of stationary pump currents between 18°C 
and 34°C on oocytes expressing ATP1A2 
WT or the P979L mutant. Analysis of the 
resulting Arrhenius plots (data not shown) 
yielded very similar activation energies 
for WT and P979L. Two temperature 
regimes were generally observed with a 
transition temperature around 26°C (see 
Table 1). Such ‘breaks’ in Arrhenius plots 
have previously been observed for e.g., 
native Na+/K+-ATPase from rat cardiac 
myocytes16 and have tentatively been 
assigned to a phase transition within the 
lipidic cell membrane. However, also these 
 measurements exclude the possibility that 
Figure 1. Functional properties of ATP1A2 mutants. (A) Stationary currents at 10 mM K+ and -30 mV 
from oocytes expressing ATP1A2 WT and mutants. Data were obtained from the following number 
of cells (in brackets): WT (139), G301R (15), R908Q (31), P979L (17) from at least five oocyte 
batches. (B) Ouabain-sensitive Rb+ uptake calculated as the difference between the mean uptake 
measured in presence of 10 μM and 10 mM ouabain, respectively (N = 21–49 cells from four 
oocyte batches). Data were normalized to the mean ouabain-sensitive Rb+ uptake of WT ATP1A2 for 
each experiment with the following normalization values (in pmole/oocyte/min): Exp. 1 (49), Exp. 
2 (130), Exp. 3 (38), Exp. 4 (61). (C and D) [K+]ext and voltage dependence of pump currents for 
ATP1A2 mutants R908Q (C), and P979L (D). Pump currents were measured in response to voltage 
steps upon addition of different [K+]ext, and amplitudes at [K+] = 10 mM and 0 mV were used for 
normalization. Different [K+] are indicated by symbols. (E and F) Voltage-dependent K0.5 values for 
R908Q (E) and P979L (F) were determined from fits of a Hill function to the data in (C and D), the 
WT curve is superimposed as dotted line for comparison. (G and H) Voltage dependence of recipro-
cal time constants from transient currents measured under extracellularly high [Na+]/K+-free condi-
tions for mutants R908Q (E), and P979L (F). The dashed line indicates the course of the WT curve 
measured under identical conditions. Data were obtained from eight (R908Q) or 20 (P979L) oocytes 
from at least three frogs. All data are given as means ± S.E.
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Figure 2. Expression of ATP1A2 constructs in Xenopus oocytes and HEK 293FT cells. (A and B) Representative western blots of samples from plasma 
membrane (PM) and total membrane (TM) fractions from oocytes expressing various ATP1A2 constructs. Samples equivalent to one oocyte were loaded 
per lane. Uninjected oocytes served as control. (C) Expression of ATP1A2 WT and mutants upon transient transfection in HEK 293FT cells and growth 
at permissive (28°C) and non-permissive (37°C) temperature. Expression of the Na+/K+-ATPase α2-subunit and β-actin (used as loading standard) was 
assessed by western blotting of whole cell lysate samples, each containing 15 μg of total protein. As an additional control for the consistency of the 
preparation, the non-disease-related polymorphism I883L13 was also investigated using this assay. This mutant was expressed in a similar manner as 
the WT enzyme. Experiments were repeated three (A and B) or five (C) times, with identical results.
Figure 3. Location of mutated residues within the Na+/K+-ATPase structure. (A and B) Structural representation of the Na+/K+-ATPase according to protein 
data bank (PDB) structure entry 3B8E with amino acids numbered according to human ATP1A2. The numbering according to the rat Na+/K+-ATPase 
α1-subunit, which underlies the 3B8E structure, is given in brackets below. Residues mutated in this study are shown in ball and stick representation, 
two red spheres indicate Rb+ ions within the cation-binding pocket as identified in the crystal structure. Structural elements outlined in color: Helix M3 
(olive) contains Gly301 (Gly296), helix M8 (light orange) contains Arg908 (Arg904), the loop between helix M9 and M10 (magenta) contains Pro979 
(Pro975). The central helix M5 is shown in green. It contains Leu797 (Leu793), whose backbone carboxyl group is the only candidate for the formation of 
an H-bond (red dashed line) to Arg908 within a radius of 5 Å. (A) Side view of the transmembrane part of the Na+/K+-ATPase α-subunit. (B) View from 
the extracellular side roughly along helix M5. In this panel, the β-subunit is also depicted (violet).
Table 1 Electrophysiological properties of ATP1A2 mutants
 V0.5 (mV) zq Turnover (s
-1) N EA (kJ/mol) 18°C–26°C EA (kJ/mol) 26°C–34°C N
WT 4.3 ± 3.5 0.82 ± 0.03 12.8 ± 3.0 18 132 ± 14 87 ± 15 5
G301R N/A N/A N/A N/A N/D N/D N/D
R908Q 8.3 ± 3.5 0.82 ± 0.03 13.0 ± 4.7 8  N/D
P979L 3.8 ± 7.1 0.79 ± 0.04 18.6 ± 5.4 21 124 ± 6 80 ± 2 5
Parameters from fits of a Boltzmann function to the voltage-dependent distributions of charge from transient currents recorded in voltage jump experiments under extracellularly high [Na+]/K+-free conditions. 
V0.5 values denote midpoint potentials, zq the slope factors (equivalent charges), and EA activation energies from Arrhenius plots derived from measurements of the temperature dependence of pump currents. N is 
the number of cells included in analysis. N/A, not applicable; N/D, not determined
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ion transporters (including the Na+/K+-ATPase α2-subunit) to 
specific microdomains of cardiomyocyte membranes to coordinate 
spatio-temporal Ca2+ signalling.23 Thus, it will be interesting to 
see whether, in addition to the already established complexity 
of molecular phenotypes, changes in subcellular localization can 
underlie ATP1A2 loss-of-function.
Concluding Remarks
Our results show that assays to investigate the consequences of 
FHM2 or SHM mutations in heterologous expression systems, 
which do not include determination of plasma membrane protein, 
are insufficient to characterize the origin of a possible loss-of-func-
tion at the level of the protein. To discriminate between molecular 
dysfunction and structure-folding-related phenomena, it would be 
helpful to combine ouabain survival assays, which are commonly 
utilized as a first test for functional defects in studies describing 
novel ATP1A2 mutations, with biotinylation studies that also 
quantify the amount of plasma membrane protein. The mutations 
R908Q and P979L are the first examples within the ATP1A2 
protein that result in completely functional enzymes, which 
are most likely defective in targeting to the plasma membrane 
(R908Q) or subject to premature degradation at body temperature 
(P979L). These observations expand the spectrum of molecular 
phenotypes of ATP1A2 mutations in sporadic and familial hemi-
plegic migraine and call for the inclusion of cell biological assays to 
clarify the correlation between the cellular fate of the protein and 
primary disease-causing processes.
Materials and Methods
Xenopus oocytes were used for expression of the ouabain-
insensitive (IC50 in mM range achieved by mutations Q116R and 
N127D)14 human Na+/K+-ATPase α2-subunit (referred to as WT 
ATP1A2) and mutants thereof, together with human β1-subunits. 
Measurements of stationary pump currents, pre-steady state 
currents, Rb+ uptake, and plasma membrane or total cellular 
membrane preparations were carried out as described.10
Expression in HEK-293FT cells and temperature shift assays. 
Amino-terminally HA-tagged human Na+/K+-ATPase α2-subunits 
were expressed together with human β1-subunits in HEK-293FT 
cells upon transient transfection of 1:1 cDNA mixtures using the 
Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA). Cells 
were grown to about 70% confluence in 10 cm Petri dishes in 
DMEM/Glutamax medium + 10% fetal bovine serum and 10 μM 
ouabain. Water-transfected cells served as control. Twenty-four 
hours after transfection, the cell charges were split and incubated 
separately at 28°C or 37°C, respectively, for an additional 24 hours. 
Subsequently, cells were harvested and subjected to whole cell lysis. 
After determination of total protein concentration in these total 
lysates using a bicinconinic acid assay (Perbio, Bonn, Germany), 
samples containing 15 μg of total protein were separated on 
sodium-dodecylsulfate polyacrylamide gels by electrophoresis 
and subsequently transferred to nitrocellulose membranes. The 
HA-tagged α2-subunits were detected with primary rat mono-
clonal anti-HA antibody 3F10 (Roche Molecular Biochemicals, 
Mannheim, Germany). β-actin was detected as a loading standard 
a change in the temperature dependence of the ion pumping rate 
underlies loss-of-function of the P979L mutant.
Since no changes in molecular function for the P979L mutant 
could be observed in oocytes we explored other expression systems 
to reveal abnormalities of the mutant protein. Preliminary experi-
ments using HeLa cells to test whether the P979L mutant was 
able to confer cell survival in ouabain-containing media1 showed 
reduced cell viability compared to WT-transfected cells, yet 
this effect was subject to substantial batch variations (data not 
shown). However, we took this as first indication that expres-
sion in mammalian cells and/or cell growth at 37°C could aid 
to discriminate between ATP1A2 WT and the P979L mutant. 
Pro979 resides within the short extracellular M9-M10 loop, where 
it ensures a rather rigid local structure, which is likely to be relaxed 
upon substitution for a leucine. This could potentially lead to a less 
effective folding or even misfolding of the structurally important 
carboxy-terminal region. It has been shown that transmembrane 
helices M5-M10 are problematic for membrane integration of the 
Na+/K+-ATPase α-subunit upon biosynthesis at the ER.17 These 
six helices probably have to be inserted into the membrane as a 
single block and may present several putative degradation signals 
when erroneously exposed to the cytoplasm.18 However, we did 
not find any indication for misfolded P979L protein in Xenopus 
oocytes, but it is known that folding defects of mutant proteins can 
be revealed in a temperature-dependent fashion. The most thor-
oughly investigated example is probably the ΔF508 mutation in 
the CFTR chloride channel, the most frequent sequence variant in 
cystic fibrosis. Cellular quality control systems for correctly folded 
membrane proteins are stringently applied to nascent CFTR 
proteins. It has been shown that the ΔF508 mutant is efficiently 
and rapidly degraded before exiting the ER in mammalian cell 
cultures.19 This effect was shown to be temperature-sensitive,20 
which easily explains why CFTR-ΔF508 could be functionally 
expressed in Xenopus oocytes.21 We therefore investigated, whether 
temperature-dependent protein degradation could occur for the 
P979L mutant. For this purpose HEK293FT cells were transfected 
with cDNA of the WT or mutant Na+/K+-ATPase α2-subunits plus 
β1-subunits. Cell batches were split 24 hours after transfection and 
subsequently grown at 28°C and 37°C. Figure 2C shows a western 
blot of cell lysates from such cell cultures. These experiments 
consistently (N = 5) showed that the amount of P979L mutant 
α2-subunit was identical to WT at 28°C, whereas a largely reduced 
protein abundance was found at 37°C. These results for the first 
time provide evidence, that a temperature-dependent effect on 
protein stability might underlie the loss of Na+/K+-ATPase func-
tion in FHM2 and expands the variety of abnormalities caused by 
mutations identified in this disease. It will be challenging to reveal 
the cellular mechanisms and pathways underlying the temperature-
dependent degradation of the Na+/K+-ATPase α2-subunit.
The spectrum of molecular phenotypes of ATP1A2 muta-
tions may still be incomplete. For instance, it has not been tested 
whether FHM2 mutations might disrupt interactions with e.g., 
adapter proteins. In this context, it is notable that the LQT4 
subtype of the cardiac long QT syndrome is caused by muta-
tions in ankyrin B,22 which is required for recruitment of certain 
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using mouse monoclonal anti-β-actin antibody AC-15 (Sigma, 
Deisenhofen, Germany). Secondary antibodies were horseradish 
peroxidase conjugates against rat or mouse (Promega, Mannheim, 
Germany), and the ECL chemiluminescence reagent (Pierce) was 
used for imaging on a Kodak Biomax film (Sigma, Deisenhofen, 
Germany).
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